Nitroglycerin Infusion

Nitroglycerin releases nitric oxide, which activates soluble guanylate cyclase inside vascular smooth muscle. This raises cyclic guanosine monophosphate, a signaling molecule that promotes smooth-muscle relaxation. The resulting venodilation reduces venous return and cardiac workload, while arterial dilation becomes more prominent as the dose increases, allowing clinicians to tailor vascular effects to the clinical situation.

At lower infusion doses, venodilation predominates, reducing the amount of blood returning to the heart and therefore lowering cardiac workload. With higher doses, arterial dilation becomes more significant, producing broader vascular effects. This dose-dependent pattern explains why clinicians adjust the infusion while observing blood pressure and symptoms rather than treating the dose as fixed.

By relaxing vascular smooth muscle, nitroglycerin can reduce the heart’s workload and alter the pressures against which it functions. These effects decrease myocardial oxygen demand and may improve the relationship between oxygen supply and demand during ischemia. The clinical objective is symptom and hemodynamic improvement without excessive vasodilation that could compromise organ perfusion.

Blood pressure and symptoms require continuous assessment because the therapeutic vascular response can become excessive. Excessive vasodilation may produce hypotension, reflex tachycardia, or reduced organ perfusion. Monitoring therefore guides dose adjustment and helps clinicians balance relief of ischemic or pressure-related cardiac stress against potentially harmful reductions in systemic circulation.

The infusion may be used for acute angina, perioperative ischemia, hypertensive emergencies, and selected cases of acute heart failure. These applications share a need for rapidly adjustable vascular effects, but the treatment goal differs by context, such as improving ischemic symptoms, controlling severe blood pressure elevation, or reducing cardiac workload during acute decompensation.

During perioperative ischemia, clinicians may use the infusion to address myocardial oxygen imbalance in a closely monitored setting. In hypertensive emergencies, the emphasis is on controlled blood-pressure reduction while avoiding hypotension and impaired organ perfusion. In both situations, symptom and blood-pressure responses determine adjustment, but the immediate clinical target differs.